Montag & Associates’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Buy
2,732
+4
+0.1% +$410 0.01% 383
2025
Q4
$290K Sell
2,728
-810
-23% -$93.9K 0.01% 364
2025
Q3
$449K Buy
3,538
+24
+0.7% +$2.86K 0.02% 318
2025
Q2
$431K Hold
3,514
0.02% 322
2025
Q1
$356K Hold
3,514
0.02% 341
2024
Q4
$325K Hold
3,514
0.02% 366
2024
Q3
$340K Buy
3,514
+1
+0% +$90 0.02% 367
2024
Q2
$301K Buy
3,513
+2
+0.1% +$168 0.02% 366
2024
Q1
$290K Buy
3,511
+11
+0.3% +$806 0.01% 369
2023
Q4
$234K Hold
3,500
0.01% 381
2023
Q3
$236K Hold
3,500
0.01% 365
2023
Q2
$238K Hold
3,500
0.01% 375
2023
Q1
$190K Hold
3,500
0.01% 389
2022
Q4
$210K Hold
3,500
0.01% 358
2022
Q3
$159K Buy
3,500
+986
+39% +$49.3K 0.01% 384
2022
Q2
$112K Hold
2,514
0.01% 423
2022
Q1
$142K Hold
2,514
0.01% 426
2021
Q4
$131K Hold
2,514
0.01% 437
2021
Q3
$150K Hold
2,514
0.01% 422
2021
Q2
$156K Hold
2,514
0.01% 416
2021
Q1
$164K Hold
2,514
0.01% 413
2020
Q4
$165K Buy
+2,514
New +$148K 0.01% 385

Other funds holding EHC

Montag & Associates's EHC Position: Q1 2026 in Review

Montag & Associates increased its Encompass Health (EHC) stake by 0.15% in Q1 2026, buying an estimated $410 and bringing the position to 2,732 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #383.

Montag & Associates first reported a position in EHC in Q4 2020 and has held it in 22 quarters since. The position peaked at $449K in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Montag & Associates held 2,732 shares of Encompass Health worth $264K as of Q1 2026.
  • Montag & Associates bought 4 Encompass Health shares in Q1 2026, an estimated $410.
  • Encompass Health made up 0.01% of Montag & Associates's portfolio in Q1 2026, its #383 holding.
  • Montag & Associates first reported a position in Encompass Health in Q4 2020 and has held it in 22 quarters since.
  • Montag & Associates's Encompass Health position peaked at $449K in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.